$CRAI

CRA International, Inc. Q2 2026 Earnings Call Summary

CRA International reported Q2 2026 record quarterly revenue, up 12.8% year over year, with 95% of its portfolio contributing. Full-year 2026 revenue guidance was raised to $805 million to $820 million, with non-GAAP EBITDA margin of 12.0% to 13.0%. The company expanded its $400 million credit facility and returned $31.4 million to shareholders.

Original reporting
Published Aug 8, 2026, 3:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 3:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CRA International, Inc. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$CRAIBullishMed
01

Why it matters

Traders can update CRAI’s 2026 revenue and margin expectations using the raised guidance range, then stress-test around utilization stability and Q3 integration friction for new hires.

02

Market read

The most tradable element is the raised 2026 revenue guidance ($805M-$820M) alongside maintained non-GAAP EBITDA margin (12%-13%) and specific operational commentary (utilization, headcount growth, DSO).

03

What to watch

DSO increased to 113 days from 100, which can pressure cash flow even if revenue guidance looks strong; also noncash forgivable loan amortization rises by $15M affecting reported/non-GAAP optics.

Relevance 8/10Novelty 7/10Timing: pre-market today, Q2 2026 earnings call summary with updated 2026 guidance

Background

The piece summarizes CRA International’s Q2 2026 earnings call, focusing on revenue drivers, operational KPIs, and full-year guidance.

Company-level read

Ticker impact

$CRAIBullishMedium confidence
Context

CRA International raised full-year 2026 revenue guidance to $805M-$820M and reiterated non-GAAP EBITDA margin of 12%-13% on its Q2 call.

Expected impact

Likely positive bias for the next earnings cycle as the raised revenue range and credit facility expansion support confidence in 2H execution.

Evidence & confidence

The article discloses specific updated guidance ranges, margin expectations, and operational KPIs (utilization, headcount growth, DSO) that directly affect valuation and near-term positioning.

Market effects

Signals continued demand strength in antitrust, legal and regulatory, and management consulting tied to M&A and AI-driven complexity, supportive for professional services sentiment.

Highlights international growth in Europe (32.9%) which may modestly support regional consulting demand expectations.

References global M&A activity as a demand driver, linking CRAI’s outlook to broader cross-border deal volumes.

Counterpoint

Raised revenue guidance may still rely on steady pipeline conversion and mid-to-upper 70s utilization, leaving downside if Q3 transitional friction worsens.

Key entities

  • CRA International, Inc.

    Professional services firm providing antitrust and competition economics, forensic services, legal and regulatory, and management consulting.

  • DOJ merger review process changes

    Management discusses DOJ changes to merger review processes and potential effects on the value of early economic analysis.

Related articles

$CRAIMed

CRA (NASDAQ:CRAI) Reports Bullish Q2 CY2026

CRA International (NASDAQ:CRAI) reported Q2 CY2026 revenue of $210.8 million, up 12.8% year over year, exceeding Wall Street’s revenue estimate by 6%, according to the company and analysts. Non-GAAP adjusted EPS was $2.16, up from $1.88 a year earlier and 0.6% above consensus. The stock rose 1.9% to $179.96 after results.

$CRAIMed

CRA INTERNATIONAL, INC. (CRAI): Results of Operations and Financial Condition

CRA INTERNATIONAL, INC. (CRAI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 craiq2-20268xkexx992xcfore.htm EX-99.2 Document Exhibit 99.2 CHARLES RIVER ASSOCIATES (CRA) SECOND QUARTER FISCAL YEAR 2026 EARNINGS ANNOUNCEMENT PREPARED CFO REMARKS CRA is providing these prepared remarks by CFO Eric Nierenberg in combination with its press release. T

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.